LINC01611

Across TCGA pan-cancer cohorts, LINC01611 RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated LINC01611 data layer.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher LINC01611 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC01611 expression acts as an unfavorable survival marker, although some lineages such as BLCA and MESO show a favorable association.

KIRP, KIRC, and ACC are the cancer types where LINC01611 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	DFS	Tertile	All	0.799	0.944	<.001	78	view →
KIRC	OS	Median	All	0.764	0.844	.005	52	view →
ACC	OS	Tertile	All	0.255	0.683	.002	47	view →
UCEC	OS	Quartile	All	0.484	0.730	<.001	44	view →
UVM	DFS	Tertile	III,IV	0.271	0.705	.022	36	view →
HNSC	OS	Median	III,IV	0.240	0.400	.008	23	view →
DLBC	DFS	Tertile	All	0.373	0.835	.009	21	view →
GBM	OS	Quartile	All	0.296	0.456	.005	18	view →
BLCA	DFS	Tertile	III,IV	0.388	0.221	.014	17	view →
MESO	OS	Median	II,III,IV	0.709	0.336	.011	17	view →
LUAD	DFS	Tertile	II,III,IV	0.712	0.490	.006	11	view →
ESCA	OS	Median	All	0.595	0.763	.013	10	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 23 lineages.

LINC01611–KIRP (DFS)

Open the KIRP breakdown →